Results 71 to 80 of about 225,598 (228)

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

Alimentary Pharmacology &Therapeutics, EarlyView.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala, Sameer Rao, Manas Gunani, Kajol Shah, Anand V. Kulkarni, Karn Wijarnpreecha, Daniel Q. Huang, Pojsakorn Danpanichkul, Ahmed Al‐Khazraji, Kaveh Hajifathalian, Vivek Lingiah, Paul Gaglio, Nikki Duong, Christine Gerula   +13 more
wiley   +1 more source

Atrial flutter ablation in a case of diuretic resistant constrictive pericarditis

Indian Heart Journal, 2015
We present a 66 year old gentleman with constrictive pericarditis and persistent atrial flutter. Initial management with oral loop diuretics was successful until he developed persistent atrial flutter.
James F. Pittaway, Emma Presern, Vrijraj S. Rathod, Krishnaraj S. Rathod, Andrew Deaner   +4 more
doaj   +1 more source

AI‐Assisted Morphometric Analysis and Molecular Phylogeny for a Dactylogyrid (Monopisthocotyla) Skin Parasite of an Ornamental Crenuchid Fish From Brazil

Acta Zoologica, EarlyView.
ABSTRACT This study presents a formal description and taxonomic appraisal of Cacatuocotyle adrianoi sp. n., a Neotropical parasite belonging to the family Dactylogyridae, integrating AI‐assisted morphometric analyses, molecular data, and phylogenetic reconstruction. Phylogenetic analyses recovered Cacatuocotyle adrianoi sp. n.
J. C. C. Aguiar, M. M. Osaki‐Pereira, N. G. Silva, P. D. Mathews, R. J. Silva   +4 more
wiley   +1 more source

Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam, Zoltán Márton Köhler, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Reverse typical atrial flutter.

, 2021
Computational simulation in the 3D human atrial model showing a reverse typical atrial flutter generated under the highest concentration of Pb2+ (300 nM). (M4V)
Juan P. Ugarte (11553060), Laura C. Palacio (11553048), Diana C. Pachajoa (11553051), Javier Saiz (180281), Catalina Tobón (281146), Geraldine Durango-Giraldo (11553054), Camilo Zapata-Hernandez (11553057), Robison Buitrago-Sierra (6421292)   +7 more
core   +1 more source

Bruton tyrosine kinase inhibitors and cardiovascular adverse events

British Journal of Pharmacology, EarlyView.
Abstract Bruton tyrosine kinase inhibitors (BTKi) have transformed the management of chronic lymphocytic leukaemia and other B‐cell malignancies, yet their therapeutic benefit is tempered by clinically relevant cardiovascular toxicities (predominantly atrial fibrillation, hypertension, bleeding and ventricular arrhythmias).
Massimiliano Camilli, Cristina Madaudo, Emanuela Salvatorelli, Giorgio Minotti, Pierantonio Menna   +4 more
wiley   +1 more source

Atrial Sounds in Atrial Flutter [PDF]

, 1971
Atrial flutter sounds are occasionally audible on bedside examination especially in patients with slow ventricular rates. A patient is described with audible flutter sounds and an illustrative phonocardiogram is presented.
Breneman, Gerald M., Duvernoy, Wolf F. C., Bostic, Oswald   +2 more
core   +1 more source

Trajectory of macrotroponin in a community cohort

Internal Medicine Journal, EarlyView.
Abstract Background Cardiac troponin I (cTnI) is a biomarker for myocardial injury. However, macrotroponin, a complex of cTnI and endogenous cardiac troponin autoantibodies, may artefactually elevate cTnI levels with potential to mislead clinicians, leading to inappropriate investigation and management.
Duncan J. Campbell, Fei Fei Gong, Michele McGrady, David L. Prior, Christopher M. Reid, Christina M. Trambas   +5 more
wiley   +1 more source

Cardiovascular Health and Atrial Fibrillation or Flutter: A Cross-Sectional Study from ELSA-Brasil. [PDF]

Arq Bras Cardiol, 2022
Santos IS, Lotufo PA, Goulart AC, Brant LCC, Pinto Filho MM, Pereira AC, Barreto SM, Ribeiro ALP, Thomas GN, Lip GYH, Bensenor IM, NIHR Global Health Research Group on Atrial Fibrillation Management, Arasalingam A, Beane A, Bensenor IM, Brocklehurst P, Cheng KK, El-Bouri W, Feng M, Goulart AC, Greenfield S, Guo Y, Guruparan M, Gusso G, Gooden TE, Haniffa R, Humphreys L, Jolly K, Jowett S, Kumarendran B, Lancashire E, Lane DA, Li X, Lip Co-Pi GYH, Li YG, Lobban T, Lotufo PA, Manseki-Holland S, Moore DJ, Nirantharakumar K, Olmos RD, Paschoal E, Pirasanth P, Powsiga U, Romagnolli C, Santos IS, Shantsila A, Sheron VA, Shribavan K, Szmigin I, Subaschandren K, Surenthirakumaran R, Tai M, Neil Thomas Co-Pi G, Varella AC, Wang H, Wang J, Zhang H, Zhong J.   +58 more
europepmc   +1 more source

Typical atrial flutter.

, 2021
Computational simulation in the 3D human atrial model showing a typical atrial flutter generated under a Pb2+ concentration of 250 nM. (M4V)
Juan P. Ugarte (11553060), Laura C. Palacio (11553048), Diana C. Pachajoa (11553051), Javier Saiz (180281), Catalina Tobón (281146), Geraldine Durango-Giraldo (11553054), Camilo Zapata-Hernandez (11553057), Robison Buitrago-Sierra (6421292)   +7 more
core   +1 more source